These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 9428829

  • 1. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH.
    Am J Med; 1997 Dec; 103(6):468-76. PubMed ID: 9428829
    [Abstract] [Full Text] [Related]

  • 2. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
    Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH.
    Am J Med; 1993 Dec; 95(6):557-67. PubMed ID: 8259772
    [Abstract] [Full Text] [Related]

  • 3. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis.
    Watts NB, Harris ST, Genant HK, Wasnich RD, Miller PD, Jackson RD, Licata AA, Ross P, Woodson GC, Yanover MJ.
    N Engl J Med; 1990 Jul 12; 323(2):73-9. PubMed ID: 2113611
    [Abstract] [Full Text] [Related]

  • 4. Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study.
    Fogelman I, Herd RJ, Blake GM, Balena R.
    Calcif Tissue Int; 2000 May 12; 66(5):348-54. PubMed ID: 10773104
    [Abstract] [Full Text] [Related]

  • 5. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T, Kollerup G, Thamsborg G, Genant HK, Sørensen OH.
    J Rheumatol; 1996 Sep 12; 23(9):1560-4. PubMed ID: 8877926
    [Abstract] [Full Text] [Related]

  • 6. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ.
    Am J Med; 1998 Mar 12; 104(3):219-26. PubMed ID: 9552083
    [Abstract] [Full Text] [Related]

  • 7. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A, Snelder AA, Mulder H.
    Am J Med; 1995 Sep 12; 99(3):235-42. PubMed ID: 7653482
    [Abstract] [Full Text] [Related]

  • 8. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.
    Thorax; 1998 May 12; 53(5):351-6. PubMed ID: 9708225
    [Abstract] [Full Text] [Related]

  • 9. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
    Watts NB, Becker P.
    Bone; 1999 Jan 12; 24(1):65-8. PubMed ID: 9916786
    [Abstract] [Full Text] [Related]

  • 10. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up).
    Meunier PJ, Confavreux E, Tupinon I, Hardouin C, Delmas PD, Balena R.
    J Clin Endocrinol Metab; 1997 Sep 12; 82(9):2784-91. PubMed ID: 9284696
    [Abstract] [Full Text] [Related]

  • 11. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis.
    Storm T, Thamsborg G, Steiniche T, Genant HK, Sørensen OH.
    N Engl J Med; 1990 May 03; 322(18):1265-71. PubMed ID: 2109197
    [Abstract] [Full Text] [Related]

  • 12. Early response to alendronate after treatment with etidronate in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Uzawa M.
    Keio J Med; 2003 Jun 03; 52(2):113-9. PubMed ID: 12862363
    [Abstract] [Full Text] [Related]

  • 13. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M.
    J Orthop Sci; 2003 Jun 03; 8(4):532-7. PubMed ID: 12898306
    [Abstract] [Full Text] [Related]

  • 14. Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: a randomized 3 year trial.
    Guañabens N, Farrerons J, Perez-Edo L, Monegal A, Renau A, Carbonell J, Roca M, Torra M, Pavesi M.
    Bone; 2000 Jul 03; 27(1):123-8. PubMed ID: 10865219
    [Abstract] [Full Text] [Related]

  • 15. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T, McGuigan L, Barbagallo S, Bryant C.
    Am J Med; 1995 May 03; 98(5):459-63. PubMed ID: 7733124
    [Abstract] [Full Text] [Related]

  • 16. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O, Fowler I, Blackwell PJ, Lawson N, Cawte SA, San P, Masud T, Hosking DJ.
    Osteoporos Int; 2000 May 03; 11(11):959-66. PubMed ID: 11193249
    [Abstract] [Full Text] [Related]

  • 17. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.
    Herd RJ, Balena R, Blake GM, Ryan PJ, Fogelman I.
    Am J Med; 1997 Aug 03; 103(2):92-9. PubMed ID: 9274891
    [Abstract] [Full Text] [Related]

  • 18. Effect of intermittent cyclical disodium etidronate therapy on bone mineral density in men with vertebral fractures.
    Anderson FH, Francis RM, Bishop JC, Rawlings DJ.
    Age Ageing; 1997 Sep 03; 26(5):359-65. PubMed ID: 9351480
    [Abstract] [Full Text] [Related]

  • 19. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S, Takada T, Katsuki Y, Kimura N, Kaneko Y, Suwa A, Hirakata M, Kuwana M.
    J Rheumatol; 2008 Jan 03; 35(1):142-6. PubMed ID: 18050368
    [Abstract] [Full Text] [Related]

  • 20. The use of etidronate and calcium versus calcium alone in the treatment of postmenopausal osteopenia: results of three years of treatment.
    Montessori ML, Scheele WH, Netelenbos JC, Kerkhoff JF, Bakker K.
    Osteoporos Int; 1997 Jan 03; 7(1):52-8. PubMed ID: 9102064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.